Home > Income Statement > PIRAMAL PHARMA

PIRAMAL PHARMA
Consolidated Net Profit

    Back to Income Statement
PIRAMAL PHARMA is part of below Screeners ↓
Best 1M Momentum Small Cap Stocks
COMMUNITY POLL
for PIRAMAL PHARMA
Please provide your vote to see the results

PIRAMAL PHARMA Last 5 Year Consolidated Net Profit History

[Consolidated]

Mar2026Mar2025Mar2024Mar2023Mar2022
Consolidated Net Profit ₹-326 Cr₹91 Cr₹18 Cr₹-186 Cr₹376 Cr

What is the latest Consolidated Net Profit of PIRAMAL PHARMA ?

The latest Consolidated Net Profit ratio of PIRAMAL PHARMA is ₹-326 Cr based on Mar2026 Consolidated results.
Year Consolidated Net Profit
Mar2026₹-326 Cr
Mar2025₹91 Cr
Mar2024₹18 Cr
Mar2023₹-186 Cr
Mar2022₹376 Cr

How is Consolidated Net Profit of PIRAMAL PHARMA Trending?

Years Consolidated Net Profit % Change
Mar2026 ₹-326 Cr
Negative
Mar2025 ₹91 Cr
411.39
Mar2024 ₹18 Cr
Positive
Mar2023 ₹-186 Cr
Negative
Mar2022 ₹376 Cr -

Compare Consolidated Net Profit of peers of PIRAMAL PHARMA

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
PIRAMAL PHARMA ₹25,747.3 Cr 9.2% 16.1% -9.3% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹474,396.0 Cr 1.8% 5.6% 16.7% Stock Analytics
DIVIS LABORATORIES ₹196,990.0 Cr 0.5% 13.1% 10.9% Stock Analytics
TORRENT PHARMACEUTICALS ₹186,354.0 Cr -2.7% 5.1% 42.4% Stock Analytics
CIPLA ₹116,705.0 Cr 2.1% -0.6% -4.5% Stock Analytics
DR REDDYS LABORATORIES ₹94,790.0 Cr -4% -17.5% -8.6% Stock Analytics


PIRAMAL PHARMA Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
PIRAMAL PHARMA

9.2%

16.1%

-9.3%

SENSEX

-0.9%

-0.4%

-6.1%


You may also like the below Video Courses